Granules Pharmaceuticals Receives One Observation from FDA InspectionBy
Granules Pharmaceuticals, a Hyderabad, India-headquartered pharmaceutical company, has completed its first inspection by the US Food and Drug Administration of its manufacturing facility in Chantilly, Virginia. The inspection took place December 4, 2017 to December 8, 2017 with the agency citing one observation.
Granules says it will respond to the observation within the stipulated time period.
Source: Granules India